Literature DB >> 1988589

Management of hemorrhagic complications from preoperative embolization of arteriovenous malformations.

P D Purdy1, H H Batjer, D Samson.   

Abstract

Endovascular embolization procedures have undergone dramatic evolution and improvement in recent years. Despite these advances, controversy remains regarding the optimal role of these procedures in treating cerebral arteriovenous malformations (AVM's) and whether their purpose should be as a presurgical adjunct or as primary therapy. This controversy risks fragmentation between disciplines in the broader efforts to improve management of cerebrovascular disorders. The authors report seven cases of life-threatening hemorrhages that occurred during staged invasive therapy for AVM's which illustrate the value of a unified team approach to optimize patient care. Each patient underwent at least one embolization procedure using polyvinyl alcohol particles, followed in two cases by the occlusion of proximal feeding vessels by platinum microcoils and in one case by the attempted detachment of an endovascular balloon. In three patients, catheter penetration into the subarachnoid space resulted in subarachnoid hemorrhage. One patient suffered rupture of a large feeding vessel during balloon inflation. The final three patients sustained intracranial hemorrhage 2 hours, 8 hours, and 5 days, respectively, following embolization. All but two patients underwent emergency craniotomy at the time of the complication. These cases underscore the advantages of interdisciplinary management optimizing decision-making and providing expeditious care when life-threatening complications develop.

Entities:  

Mesh:

Year:  1991        PMID: 1988589     DOI: 10.3171/jns.1991.74.2.0205

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  22 in total

1.  Cerebral arteriovenous malformations.

Authors: 
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

2.  Risk factors of intracranial hemorrhage after brain AVM interventional therapy and its effects on prognosis.

Authors:  Guobin Li; Kun Han; Haiying Yang; Hui Huang; Hong Yang; Dezhang Zhu
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  [Recommendations of the European Stroke Initiative for the diagnosis and treatment of spontaneous intracerebral haemorrhage].

Authors:  S Külkens; P Ringleb; J Diedler; W Hacke; T Steiner
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

4.  Endothelial-cell injury of the basilar artery caused by ethanol infusion in dogs.

Authors:  H Kobayashi; H Ide; M Kabuto; Y Handa; T Kubota
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

Review 5.  Endovascular management of arteriovenous malformations of the brain.

Authors:  Charles A Bruno; Philip M Meyers
Journal:  Interv Neurol       Date:  2013-09

6.  Morbidity and healthcare costs of vascular anomalies: a national study.

Authors:  Jina Kim; Zhifei Sun; Harold J Leraas; Uttara P Nag; Ehsan Benrashid; Alexander C Allori; Waleska M Pabon-Ramos; Henry E Rice; Cynthia K Shortell; Elisabeth T Tracy
Journal:  Pediatr Surg Int       Date:  2016-11-22       Impact factor: 1.827

7.  N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial.

Authors: 
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

8.  Predictors of hemorrhagic complications from endovascular treatment of cerebral arteriovenous malformations.

Authors:  José A Jordan; Juan Carlos Llibre; Frank Vázquez; Raúl Rodríguez; José A Prince; José Carlos Ugarte
Journal:  Interv Neuroradiol       Date:  2014-02-10       Impact factor: 1.610

9.  Early surgical treatment of intracerebral hemorrhages caused by AVM: our experience in 10 cases.

Authors:  F Puzzilli; L Mastronardi; A Ruggeri; P Lunardi
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

Review 10.  The combined management of cerebral arteriovenous malformations. Experience with 100 cases and review of the literature.

Authors:  R Deruty; I Pelissou-Guyotat; C Mottolese; Y Bascoulergue; D Amat
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.